Market Place
Sourcing Support
All News #Library
Biotech
Pacira Shows EXPAREL Cuts Costs In Outpatient Joint Surgeries
13 Apr 2026 //
GLOBENEWSWIRE
Pacira Presents Real-World Data From IGOR Outcomes Registry
02 Mar 2026 //
GLOBENEWSWIRE
Pacira BioSciences Names Hirawat, M.D., to Board
28 Jan 2026 //
GLOBENEWSWIRE
Pacira Biosciences Reports Positive 12-Month Study On Iovera
02 Dec 2025 //
GLOBENEWSWIRE
Pacira BioSciences Reports Third Quarter 2025 Financial Results
06 Nov 2025 //
GLOBENEWSWIRE
Pacira Biosciences Completes Phase 2 Enrollment For PCRX-201
05 Nov 2025 //
GLOBENEWSWIRE
Pacira Reports 3-Year Data for PCRX-201 in Knee Osteoarthritis
28 Oct 2025 //
GLOBENEWSWIRE
Pacira Bio to Present Data from 3 Real-World Studies with Exparel
23 Oct 2025 //
GLOBENEWSWIRE
Pacira Biosciences To Unveil 3-Year Data On PCRX-201 Gene
20 Oct 2025 //
GLOBENEWSWIRE
Pacira Cuts 8% of Staff, Shuts Down California Facility
11 Jul 2025 //
FIERCE PHARMA
Pacira Bio Reveals Three-Year Data on Gene Therapy PCRX-201
11 Jun 2025 //
GLOBENEWSWIRE
Pacira Bio Presents New Data on PCRX-201 in Knee Osteoarthritis
15 May 2025 //
GLOBENEWSWIRE
Pacira To Present 3-Year Data On PCRX-201
06 May 2025 //
GLOBENEWSWIRE
Pacira Bio to Present New Data on Immunogenicity of PCRX-201
02 May 2025 //
GLOBENEWSWIRE
Pacira BioSciences: First Patient Dosed in PCRX-201 Study
03 Apr 2025 //
GLOBENEWSWIRE
Pacira BioSciences Receives Director Nominations from DOMA Perpet
14 Mar 2025 //
GLOBENEWSWIRE
Pacira Announces 104-Week Data On PCRX-201 For Osteoarthritis
26 Sep 2024 //
GLOBENEWSWIRE
Pacira BioSciences Reports Inducement Grants Under Nasdaq
09 Sep 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.